Close
4

Seqens Seqens

X

Company profile for Adimmune

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Founded in 1965, Adimmune Corporation (ADIM) is the only influenza vaccine manufacturer with both EU GMP and US FDA certification in Asia, as well as the only PIC/S GMP manufacturer of human vaccines in Taiwan. ADIM’s major products include Trivalent Influenza vaccine, Tetravalent Influenza vaccine, Influenza A (H1N1) Virus Monovalent Vaccine, Japanese Encephalitis Vaccine (JEV), and Tetanus toxoid, and purified Tuberculin. ...
Founded in 1965, Adimmune Corporation (ADIM) is the only influenza vaccine manufacturer with both EU GMP and US FDA certification in Asia, as well as the only PIC/S GMP manufacturer of human vaccines in Taiwan. ADIM’s major products include Trivalent Influenza vaccine, Tetravalent Influenza vaccine, Influenza A (H1N1) Virus Monovalent Vaccine, Japanese Encephalitis Vaccine (JEV), and Tetanus toxoid, and purified Tuberculin. Our foreign technical cooperation partners includ Kitasato Daiichi Sankyo Co., Ltd. , Japan's largest vaccine researcher and manufacturer (formerly known as Kitasato Institute) and Crucell N.V.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Adimmune
Taiwan Flag
Country
Country
Taiwan
Address
Address
No. 3, Sec. 1, Tanxing Rd., Tanzi Dist., Taichung City 42743
Telephone
Telephone
+886-4-25381220
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY